Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

EDAP US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

EDAP US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Edap Tms Sa American Depositary Receipt(EDAP US)

$3.32-0.9321.88%Ext:$3.20-0.123.59%(Market Closed · 00:53:41 UTC)
ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees

Edap Tms Sa American Depositary Receipt(EDAP US)

$3.32-0.9321.88%Ext:$3.20-0.123.59%(Market Closed · 00:53:41 UTC)
ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees
Ask AI
Ask AI

Edap Tms Sa American Depositary Receipt — Company Profile

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.

Sector
Industrials
Industry
Commercial Services & Supplies
Exchange
UQ
CEO
Ryan Rhodes
Headquarters
Vaulx-en-Velin, AR, FR
IPO Date
Aug 1, 1997
Employees
289
Website
www.focalone.com

Key Metrics

Price
$4.33
Market Cap
$162.30M
Revenue (TTM)
$17.88M
Net Income (TTM)
$-9116015.00
EPS (TTM)
-0.24
P/E (TTM)
0.00
P/B (TTM)
16.07
Dividend Yield
0.00%
ROE (TTM)
-90.25%
ROA (TTM)
-12.65%
Operating Margin
-41.35%

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.

Website
www.focalone.com
Location
Vaulx-en-Velin, AR, FR
Phone33 4 72 15 31 50
Employees289
CEORyan Rhodes
Sector
Industrials
Industry
Commercial Services & Supplies
IPO DateAug 1, 1997

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

News

  • EDAP TMS S.A. (FOCL) Q3 2026 Earnings Call Transcript05:44AM
  • FocalTherics Q3 Earnings Call Highlights6 Nov
  • FocalTherics™ Reports Third Quarter 2026 Financial Results5 Nov
  • FocalTherics™ to Participate in Upcoming Investor Conferences4 Nov
  • FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 202622 Oct
  • FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference1 Sep
  • Analysts Set FocalTherics (NASDAQ:FOCL) Target Price at $9.0017 Aug
  • EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript13 Aug
  • FocalTherics Q2 Earnings Call Highlights13 Aug
  • FocalTherics™ Reports Second Quarter 2026 Financial Results13 Aug
  • FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares11 Aug
  • FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 202611 Aug
  • FocalTherics™ Announces Proposed Public Offering of American Depositary Shares11 Aug

Key Stats

Trading

Px/Chg 1D$4.33 / +3.10%
Avg Volume44.58K
BetaN/A
Mkt Cap162.30M
FD Mkt Cap161.55M

Float

Shrs Out/Float37.48M / 37.28M
Short Float0.01%
Days to Cover4.03
Stock Repurchased$0.00

Current Valuation

EV175.08M
EV/EBITDA0.00
EV/Sales0.00
P/B16.07
P/S0.00
FCF Yield-2.30%
ROE-90.25%
ROA-12.65%
Current Ratio1.34

Estimates

P/E0.00
Est P/E0.00
Est EPS-0.20
Est PEG0.00

Valuation

Metric5Yr AvgOct '26
PRICE-BASED RATIOS
Price / Earnings-17.80-17.80
Price / Sales9.089.08
Price / Book Value16.0716.07
Price / Free Cash Flow-43.40-43.40
ENTERPRISE VALUE METRICS
Enterprise Value175.1175.1
Enterprise Value / Sales9.799.79
Enterprise Value / EBITDA-27.57-27.57
Enterprise Value / EBIT-24.15-24.15

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '25
INCOME STATEMENT
Revenue—70.7
Gross Income—30.1
EBITDA—-25.0
EBIT—-28.5
Net Income—-29.3
EPS (Diluted)—-0.78
BALANCE SHEET
Cash & ST Inv—20.5
Total Assets—79.0
Total Liabilities—59.6
Total Shareholder Equity—19.4
CASH FLOW
Net Operating Cash Flow—-16.5
Cap Ex—-4.9
Free Cash Flow—-21.4

Enterprise Value Bridge

Millions USD6 Nov '26
Price (As of 6 Nov '26)3.33
Basic Shares37.48
Market Cap124.8
Diluted Shares42.63
Fully Diluted Shares Outstanding42.63
Fully Diluted Market Cap141.9
+Consolidated Debt13.3
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-56.3
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value81.8

Related companies

Apple Inc.

AAPL US

Kla Corp

KLAC US

Medtronic Public Limited Company

MDT US

Stryker Corp

SYK US

3M Company

MMM US

Northrop Grumman Corp /DE/

NOC US

Coherent Corp.

COHR US

Boston Scientific Corp

BSX US

Lenovo Group Ltd

LNVGY US

Garmin Ltd

GRMN US

HOYA Corporation

HOCPY US

Becton Dickinson & Co

0R19 LN

Edap Tms Sa American Depositary Receipt — Company Profile

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.

Sector
Industrials
Industry
Commercial Services & Supplies
Exchange
UQ
CEO
Ryan Rhodes
Headquarters
Vaulx-en-Velin, AR, FR
IPO Date
Aug 1, 1997
Employees
289
Website
www.focalone.com

Key Metrics

Price
$4.33
Market Cap
$162.30M
Revenue (TTM)
$17.88M
Net Income (TTM)
$-9116015.00
EPS (TTM)
-0.24
P/E (TTM)
0.00
P/B (TTM)
16.07
Dividend Yield
0.00%
ROE (TTM)
-90.25%
ROA (TTM)
-12.65%
Operating Margin
-41.35%

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.

Website
www.focalone.com
Location
Vaulx-en-Velin, AR, FR
Phone33 4 72 15 31 50
Employees289
CEORyan Rhodes
Sector
Industrials
Industry
Commercial Services & Supplies
IPO DateAug 1, 1997

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

News

  • EDAP TMS S.A. (FOCL) Q3 2026 Earnings Call Transcript05:44AM
  • FocalTherics Q3 Earnings Call Highlights6 Nov
  • FocalTherics™ Reports Third Quarter 2026 Financial Results5 Nov
  • FocalTherics™ to Participate in Upcoming Investor Conferences4 Nov
  • FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 202622 Oct
  • FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference1 Sep
  • Analysts Set FocalTherics (NASDAQ:FOCL) Target Price at $9.0017 Aug
  • EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript13 Aug
  • FocalTherics Q2 Earnings Call Highlights13 Aug
  • FocalTherics™ Reports Second Quarter 2026 Financial Results13 Aug
  • FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares11 Aug
  • FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 202611 Aug
  • FocalTherics™ Announces Proposed Public Offering of American Depositary Shares11 Aug

Key Stats

Trading

Px/Chg 1D$4.33 / +3.10%
Avg Volume44.58K
BetaN/A
Mkt Cap162.30M
FD Mkt Cap161.55M

Float

Shrs Out/Float37.48M / 37.28M
Short Float0.01%
Days to Cover4.03
Stock Repurchased$0.00

Current Valuation

EV175.08M
EV/EBITDA0.00
EV/Sales0.00
P/B16.07
P/S0.00
FCF Yield-2.30%
ROE-90.25%
ROA-12.65%
Current Ratio1.34

Estimates

P/E0.00
Est P/E0.00
Est EPS-0.20
Est PEG0.00

Valuation

Metric5Yr AvgOct '26
PRICE-BASED RATIOS
Price / Earnings-17.80-17.80
Price / Sales9.089.08
Price / Book Value16.0716.07
Price / Free Cash Flow-43.40-43.40
ENTERPRISE VALUE METRICS
Enterprise Value175.1175.1
Enterprise Value / Sales9.799.79
Enterprise Value / EBITDA-27.57-27.57
Enterprise Value / EBIT-24.15-24.15

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '25
INCOME STATEMENT
Revenue—70.7
Gross Income—30.1
EBITDA—-25.0
EBIT—-28.5
Net Income—-29.3
EPS (Diluted)—-0.78
BALANCE SHEET
Cash & ST Inv—20.5
Total Assets—79.0
Total Liabilities—59.6
Total Shareholder Equity—19.4
CASH FLOW
Net Operating Cash Flow—-16.5
Cap Ex—-4.9
Free Cash Flow—-21.4

Enterprise Value Bridge

Millions USD6 Nov '26
Price (As of 6 Nov '26)3.33
Basic Shares37.48
Market Cap124.8
Diluted Shares42.63
Fully Diluted Shares Outstanding42.63
Fully Diluted Market Cap141.9
+Consolidated Debt13.3
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-56.3
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value81.8

Related companies

Apple Inc.

AAPL US

Kla Corp

KLAC US

Medtronic Public Limited Company

MDT US

Stryker Corp

SYK US

3M Company

MMM US

Northrop Grumman Corp /DE/

NOC US

Coherent Corp.

COHR US

Boston Scientific Corp

BSX US

Lenovo Group Ltd

LNVGY US

Garmin Ltd

GRMN US

HOYA Corporation

HOCPY US

Becton Dickinson & Co

0R19 LN